<?xml version="1.0" encoding="UTF-8"?><faers xmlns="http://fda.gov/ns/faers"><meta><status>PENDING</status><version>v2</version><patient-age>9</patient-age><report-id>PHHY2012JP102817</report-id><gender>male</gender><reactions><reaction>Suspected mycoplasma infection</reaction><reaction>Cough</reaction></reactions><drugs><drug><ndc>59572983</ndc><drug-name>TEGRETOL</drug-name><manufacturer/><ingredients/></drug><drug><ndc>59572983</ndc><drug-name>MUCODYNE</drug-name><manufacturer/><ingredients/></drug><drug><ndc>59572983</ndc><drug-name>HOKUNALIN</drug-name><manufacturer/><ingredients/></drug></drugs><indications><indication>Epilepsy</indication></indications><patient-age>9</patient-age><outcomes/><country>Japan</country><geo/></meta><original><ichicsr lang="en" xmlns="">
	<ichicsrmessageheader>
		<messagetype>ichicsr</messagetype>
		<messageformatversion>2.1</messageformatversion>
		<messageformatrelease>2.0</messageformatrelease>
		<messagenumb>4053174_286</messagenumb>
		<messagesenderidentifier>NovartisPH</messagesenderidentifier>
		<messagereceiveridentifier>ZZFDA</messagereceiveridentifier>
		<messagedateformat>204</messagedateformat>
		<messagedate>20121211134153</messagedate>
	</ichicsrmessageheader>
	<safetyreport>
		<safetyreportversion>2</safetyreportversion>
		<safetyreportid>PHHY2012JP102817</safetyreportid>
		<primarysourcecountry>JP</primarysourcecountry>
		<occurcountry>JP</occurcountry>
		<transmissiondateformat>102</transmissiondateformat>
		<transmissiondate>2012-12-11</transmissiondate>
		<reporttype>1</reporttype>
		<serious code="1">Yes</serious>
		<seriousnessdeath>2</seriousnessdeath>
		<seriousnesslifethreatening>2</seriousnesslifethreatening>
		<seriousnesshospitalization>2</seriousnesshospitalization>
		<seriousnessdisabling>2</seriousnessdisabling>
		<seriousnesscongenitalanomali>2</seriousnesscongenitalanomali>
		<seriousnessother>1</seriousnessother>
		<receivedateformat>102</receivedateformat>
		<receivedate>2012-11-05</receivedate>
		<receiptdateformat>102</receiptdateformat>
		<receiptdate>2012-12-06</receiptdate>
		<additionaldocument>2</additionaldocument>
		<fulfillexpeditecriteria>1</fulfillexpeditecriteria>
		<companynumb>PHHY2012JP102817</companynumb>
		<medicallyconfirm>1</medicallyconfirm>
		<primarysource>
			<reporterfamilyname>PRIVACY</reporterfamilyname>
			<reportercountry>JP</reportercountry>
			<qualification code="1">Physician</qualification>
		</primarysource>
		<sender>
			<sendertype>1</sendertype>
			<senderorganization>NOVARTIS PHARMACEUTICAL CORPORATION</senderorganization>
			<senderdepartment>Clinical Safety and Epidemiology</senderdepartment>
			<senderfamilyname>Clinical Safety and Epidemiology</senderfamilyname>
			<senderstreetaddress>Novartis Pharmaceuticals Corp. Bldg 419, One Health Plaza</senderstreetaddress>
			<sendercity>East Hanover</sendercity>
			<senderstate>NJ</senderstate>
			<senderpostcode>07936</senderpostcode>
			<sendercountrycode>US</sendercountrycode>
			<sendertel>+1800378</sendertel>
			<sendertelextension>8567</sendertelextension>
			<sendertelcountrycode>US</sendertelcountrycode>
			<senderfax>+1973781</senderfax>
			<senderfaxextension>8001</senderfaxextension>
			<senderfaxcountrycode>US</senderfaxcountrycode>
			<senderemailaddress>gdss.configuration@pharma.novartis.com</senderemailaddress>
		</sender>
		<receiver>
			<receivertype>2</receivertype>
			<receiverorganization>ZZFDA</receiverorganization>
			<receiverdepartment>FDA</receiverdepartment>
			<receivertitle>Mr</receivertitle>
			<receivergivename>William</receivergivename>
			<receiverfamilyname>Taylor</receiverfamilyname>
			<receiverstreetaddress>5600 Fishers Lane Room 16B-45</receiverstreetaddress>
			<receivercity>Rockville</receivercity>
			<receiverstate>MD</receiverstate>
			<receiverpostcode>20857</receiverpostcode>
			<receivercountrycode>US</receivercountrycode>
			<receivertel>+1301827</receivertel>
			<receivertelextension>0964</receivertelextension>
			<receivertelcountrycode>US</receivertelcountrycode>
			<receiverfax>+1301594</receiverfax>
			<receiverfaxextension>0829</receiverfaxextension>
			<receiverfaxcountrycode>US</receiverfaxcountrycode>
			<receiveremailaddress>.</receiveremailaddress>
		</receiver>
		<patient>
			<patientinitial>HK</patientinitial>
			<patientonsetage>9</patientonsetage>
			<patientonsetageunit>801</patientonsetageunit>
			<patientsex code="1">Male</patientsex>
			<medicalhistoryepisode>
				<patientepisodenamemeddraversion>15.1</patientepisodenamemeddraversion>
				<patientepisodename>Febrile convulsion</patientepisodename>
			</medicalhistoryepisode>
			<medicalhistoryepisode>
				<patientepisodenamemeddraversion>15.1</patientepisodenamemeddraversion>
				<patientepisodename>Developmental delay</patientepisodename>
			</medicalhistoryepisode>
			<reaction>
				<primarysourcereaction>Suspected mycoplasma infection</primarysourcereaction>
				<reactionmeddraversionllt>15.1</reactionmeddraversionllt>
				<reactionmeddrallt>Mycoplasma infection</reactionmeddrallt>
				<reactionmeddraversionpt>15.1</reactionmeddraversionpt>
				<reactionmeddrapt>Mycoplasma infection</reactionmeddrapt>
				<termhighlighted>4</termhighlighted>
				<reactionstartdateformat>102</reactionstartdateformat>
				<reactionstartdate>20121105</reactionstartdate>
				<reactionoutcome code="1">recovered/resolved</reactionoutcome>
			</reaction>
			<reaction>
				<primarysourcereaction>Cough</primarysourcereaction>
				<reactionmeddraversionllt>15.1</reactionmeddraversionllt>
				<reactionmeddrallt>Cough</reactionmeddrallt>
				<reactionmeddraversionpt>15.1</reactionmeddraversionpt>
				<reactionmeddrapt>Cough</reactionmeddrapt>
				<reactionoutcome code="1">recovered/resolved</reactionoutcome>
			</reaction>
			<drug>
				<drugcharacterization code="1">suspsect</drugcharacterization>
				<medicinalproduct>TEGRETOL</medicinalproduct>
				<obtaindrugcountry>JP</obtaindrugcountry>
				<drugauthorizationnumb>16-608</drugauthorizationnumb>
				<drugauthorizationcountry>JP</drugauthorizationcountry>
				<drugauthorizationholder>NOVARTIS SECTOR: PHARMA</drugauthorizationholder>
				<drugstructuredosagenumb>100</drugstructuredosagenumb>
				<drugstructuredosageunit code="003">milligrams</drugstructuredosageunit>
				<drugdosagetext>100 mg, daily</drugdosagetext>
				<drugadministrationroute code="048">Oral</drugadministrationroute>
				<drugindicationmeddraversion>15.1</drugindicationmeddraversion>
				<drugindication>Epilepsy</drugindication>
				<actiondrug code="4">Dose not changed</actiondrug>
				<activesubstance>
					<activesubstancename>CARBAMAZEPINE</activesubstancename>
				</activesubstance>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Cough</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Cough</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Mycoplasma infection</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Mycoplasma infection</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not Suspected</drugresult>
				</drugreactionrelatedness>
			</drug>
			<drug>
				<drugcharacterization code="1">suspsect</drugcharacterization>
				<medicinalproduct>MUCODYNE</medicinalproduct>
				<obtaindrugcountry>JP</obtaindrugcountry>
				<drugauthorizationcountry>JP</drugauthorizationcountry>
				<drugadministrationroute code="048">Oral</drugadministrationroute>
				<actiondrug code="5">Unknown</actiondrug>
				<drugrecurreadministration code="3">Unknown</drugrecurreadministration>
				<activesubstance>
					<activesubstancename>CARBOCISTEINE</activesubstancename>
				</activesubstance>
			</drug>
			<drug>
				<drugcharacterization code="1">suspsect</drugcharacterization>
				<medicinalproduct>HOKUNALIN</medicinalproduct>
				<obtaindrugcountry>JP</obtaindrugcountry>
				<drugauthorizationcountry>JP</drugauthorizationcountry>
				<drugadministrationroute code="062">Transdermal</drugadministrationroute>
				<actiondrug code="5">Unknown</actiondrug>
				<drugrecurreadministration code="3">Unknown</drugrecurreadministration>
				<activesubstance>
					<activesubstancename>TULOBUTEROL HYDROCHLORIDE</activesubstancename>
				</activesubstance>
			</drug>
			<summary>
				<narrativeincludeclinical>Case number PHHY2012JP102817, is an <Semaphore x="1938518" class="Disease or Finding" value="First-Degree Burn" score="1.00" ID="C76130">initial </Semaphore>spontaneous report received from a <Semaphore x="2398439" class="Occupation" value="Physician" score="1.00" ID="C25741">physician </Semaphore>on 05 Nov 2012. Follow up report received from a <Semaphore x="2398439" class="Occupation" value="Physician" score="1.00" ID="C25741">physician </Semaphore>(<Semaphore x="2305971" class="Occupation" value="Neurologist" score="1.00" ID="C17721">neurologist</Semaphore>) on 06 Dec 2012. This report refers to a 09-year old male patient. The patient's medical history included <Semaphore x="2949961" class="MedDRA LLT" value="Febrile convulsion" score="1.00" ID="10016284">febrile <Semaphore x="2880673" class="MedDRA LLT" value="Convulsion" score="1.00" ID="10010904">convulsion </Semaphore></Semaphore>and the concurrent condition <Semaphore x="1845059" class="Disease or Finding" value="Developmental Disorder" score="1.00" ID="C89330">developmental disorder</Semaphore>. The patient received <Semaphore x="1250514" class="Medicine" value="TEGretol" score="0.97" ID="241412">Tegretol </Semaphore>(<Semaphore x="300595" class="Medicine" value="Carbamazepine" score="0.49" ID="241093">carbamazepine</Semaphore>) for <Semaphore x="1892352" class="Disease or Finding" value="Epilepsy" score="1.00" ID="C3020">epilepsy </Semaphore>at a dose of 100 mg daily, prescribed by a medical institution other than the reporting clinic. The patient also received Mucodyne (carbocisteine) <Semaphore x="2336704" class="AnatomicStructure" value="Oral Cavity" score="1.00" ID="C12421">orally </Semaphore>and Hokunalin tape (<Semaphore x="1305479" class="Medicine" value="tulobuterol" score="0.49" ID="266537">tulobuterol</Semaphore>) transdermal. On 05 Nov 2012, the patient developed a suspected <Semaphore x="3118845" class="MedDRA LLT" value="Mycoplasma infection" score="1.00" ID="10061300">mycoplasma infection</Semaphore>. On an unknown date, the patient also developed <Semaphore x="1818376" class="Procedure" value="Cough When Drinking Liquids" score="1.00" ID="C104456">cough</Semaphore>. <Semaphore x="2610768" class="Procedure" value="Therapeutic Procedure" score="1.00" ID="C49236">Treatment </Semaphore>with <Semaphore x="1250514" class="Medicine" value="TEGretol" score="0.97" ID="241412">Tegretol </Semaphore>was ongoing. The <Semaphore x="2398439" class="Occupation" value="Physician" score="1.00" ID="C25741">physician </Semaphore>reported that the course of <Semaphore x="3118845" class="MedDRA LLT" value="Mycoplasma infection" score="1.00" ID="10061300">mycoplasma infection </Semaphore>after the previous report was uncertain. From the condition of the patient, it was considered that the patient recovered from <Semaphore x="3118845" class="MedDRA LLT" value="Mycoplasma infection" score="1.00" ID="10061300">mycoplasma infection</Semaphore>. The event suspected <Semaphore x="3118845" class="MedDRA LLT" value="Mycoplasma infection" score="1.00" ID="10061300">mycoplasma infection </Semaphore>was considered non serious and for other event it was not reported. The <Semaphore x="2353201" class="Disease or Finding" value="Outcome" score="1.00" ID="C20200">outcome </Semaphore>of events was <Semaphore x="1803876" class="Disease or Finding" value="Complete Recovery" score="1.00" ID="C82467">complete recovery</Semaphore>. The events were considered not suspected by <Semaphore x="2398439" class="Occupation" value="Physician" score="1.00" ID="C25741">physician</Semaphore>. The <Semaphore x="2398439" class="Occupation" value="Physician" score="1.00" ID="C25741">physician </Semaphore>commented that <Semaphore x="1250514" class="Medicine" value="TEGretol" score="0.97" ID="241412">Tegretol </Semaphore>was given for <Semaphore x="1892352" class="Disease or Finding" value="Epilepsy" score="1.00" ID="C3020">epilepsy </Semaphore>I (the <Semaphore x="2398439" class="Occupation" value="Physician" score="1.00" ID="C25741">physician</Semaphore>) was not aware of <Semaphore x="3118845" class="MedDRA LLT" value="Mycoplasma infection" score="1.00" ID="10061300">mycoplasma infection</Semaphore>. It was considered that the patient recovered from <Semaphore x="3118845" class="MedDRA LLT" value="Mycoplasma infection" score="1.00" ID="10061300">mycoplasma infection</Semaphore>. There was no causal relation between <Semaphore x="1250514" class="Medicine" value="TEGretol" score="0.97" ID="241412">Tegretol </Semaphore>and <Semaphore x="3118845" class="MedDRA LLT" value="Mycoplasma infection" score="1.00" ID="10061300">mycoplasma infection</Semaphore>.Follow up report received from a <Semaphore x="2398439" class="Occupation" value="Physician" score="1.00" ID="C25741">physician </Semaphore>(<Semaphore x="2305971" class="Occupation" value="Neurologist" score="1.00" ID="C17721">neurologist</Semaphore>) on 06 Dec 2012: Updated suspect <Semaphore x="1864691" class="Procedure" value="Drug Therapy" score="1.00" ID="C95761">drug <Semaphore x="1250514" class="Medicine" value="TEGretol" score="0.97" ID="241412">Tegretol </Semaphore>therapy </Semaphore>details (indication and dose), updated events seriousness, <Semaphore x="2353201" class="Disease or Finding" value="Outcome" score="1.00" ID="C20200">outcome </Semaphore>and causality, added <Semaphore x="2398439" class="Occupation" value="Physician" score="1.00" ID="C25741">physician </Semaphore>comments and narrative were updated.</narrativeincludeclinical>
				<sendercomment>
Based on review of available reported data the events are not suspected. Better explained by alternative causal factor of infectious etiology</sendercomment>
			</summary>
		</patient>
	</safetyreport>
</ichicsr></original></faers>